| P50 | author | Joseph H Callicott | Q30348359 |
| P2093 | author name string | A Bertolino | |
| | M Egan | |
| | D R Weinberger | |
| | J A Frank | |
| | J Bachevalier | |
| | V S Mattay | |
| | M B Knable | |
| | R C Saunders | |
| | B Kolachana | |
| P2860 | cites work | Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging | Q48854560 |
| | Persistent elevations in dopamine and its metabolites in the nucleus accumbens after mild subchronic stress in rats with ibotenic acid lesions of the medial prefrontal cortex | Q48857890 |
| | Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging | Q48956318 |
| | The effect of surgical lesions to frontal cortex and substantia nigra on amphetamine responses in rats | Q51122804 |
| | Augmentation of prefrontal cortical monoaminergic activity inhibits dopamine release in the caudate nucleus: an in vivo neurochemical assessment in the rhesus monkey. | Q51586909 |
| | Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors. | Q51604125 |
| | Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. | Q51994574 |
| | Regional brain activity in chronic schizophrenic patients during the performance of a verbal fluency task. | Q52014101 |
| | Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients. | Q52021168 |
| | 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. | Q52055580 |
| | Chemical pathology of acute demyelinating lesions and its correlation with disability | Q57043095 |
| | 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms | Q57781187 |
| | Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia | Q62601732 |
| | Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens. An in vivo voltammetric study | Q69591972 |
| | The effect of N-acetylaspartate on the intracellular free calcium concentration in NTera2-neurons | Q70875776 |
| | Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain | Q71832825 |
| | Cortical Regulation of Subcortical Dopamine Release: Mediation via the Ventral Tegmental Area | Q71978525 |
| | Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy | Q72355934 |
| | Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study | Q72367731 |
| | Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis | Q72565124 |
| | Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging | Q73966033 |
| | Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects | Q22248075 |
| | A neural substrate of prediction and reward | Q27860851 |
| | Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency | Q28260144 |
| | Expressed emotion and psychiatric relapse: a meta-analysis | Q28274262 |
| | Implications of normal brain development for the pathogenesis of schizophrenia | Q29618740 |
| | Provocative tests with psychostimulant drugs in schizophrenia | Q34559517 |
| | Dopamine in schizophrenia: a review and reconceptualization | Q34568816 |
| | Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia | Q35947887 |
| | Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method | Q36050571 |
| | Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy | Q36185748 |
| | Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia | Q36500321 |
| | Multisection proton MR spectroscopic imaging of the brain | Q36785034 |
| | The determinants of stress-induced activation of the prefrontal cortical dopamine system | Q37800392 |
| | Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground | Q40424300 |
| | D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride | Q41173321 |
| | Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia | Q41482417 |
| | Central nervous system trans‐synaptic effects of acute axonal injury: a 1h magnetic resonance spectroscopy study | Q41673623 |
| | The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area. | Q42515391 |
| | Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence | Q44240058 |
| | The generalized pattern of neuropsychological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test results | Q44275686 |
| | Dopamine receptor subtype imbalance in schizophrenia | Q45078544 |
| | Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease | Q45295751 |
| | Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. | Q45307345 |
| | 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine. | Q48126381 |
| | Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains | Q48166703 |
| | Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography | Q48186320 |
| | Selective activation of mesocortical DA system by stress | Q48363490 |
| | Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. | Q48378899 |
| | Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins | Q48459684 |
| | Neonatal lesions of the medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine | Q48461442 |
| | Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: a proton magnetic resonance spectroscopic imaging study | Q48572568 |
| | Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia. | Q48577168 |
| | Imaging D2 receptor occupancy by endogenous dopamine in humans | Q48632608 |
| | Decreased left frontal lobe N-acetylaspartate in schizophrenia | Q48721724 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| | dopamine | Q170304 |
| | striatum | Q1319792 |
| P304 | page(s) | 660-667 | |
| P577 | publication date | 1999-03-01 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia | |
| P478 | volume | 45 | |